Thailand - Delayed Quote • THB
JSP Pharmaceutical Manufacturing (Thailand) Public Co., Ltd. (JSP.BK)
At close: 4:35 PM GMT+7
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
575,577.8530
575,577.8530
458,074.5790
422,341.6410
455,644.2310
Cost of Revenue
431,103.2420
431,103.2420
313,112.3260
277,973.0000
310,016.0000
Gross Profit
144,474.6110
144,474.6110
144,962.2530
144,368.6410
145,628.2310
Operating Expense
144,473.3010
144,473.3010
145,867.4830
96,071.2820
90,387.7530
Operating Income
1.3100
1.3100
-905.2300
48,297.3590
55,240.4780
Net Non Operating Interest Income Expense
-12,995.5630
-12,995.5630
-9,187.9470
-10,400.8070
-11,440.7590
Other Income Expense
50,546.7480
50,546.7480
8,721.5380
-466.8450
-4,122.7070
Pretax Income
37,552.4950
37,552.4950
-1,371.6390
37,430.0730
39,676.4300
Tax Provision
9,312.7450
9,312.7450
1,695.8240
7,738.9570
8,592.6240
Net Income Common Stockholders
-1,268.8540
-1,268.8540
-17,482.7710
29,691.1160
31,083.8060
Diluted NI Available to Com Stockholders
-1,268.8540
-1,268.8540
-17,482.7710
29,691.1160
31,083.8060
Basic EPS
-0.01
-0.01
-0.04
0.08
0.07
Diluted EPS
-0.01
-0.01
-0.04
0.08
0.07
Basic Average Shares
474,555.0000
474,555.0000
437,069.2750
360,479.0000
455,000.0000
Diluted Average Shares
474,555.0000
474,555.0000
437,069.2750
360,479.0000
455,000.0000
Total Operating Income as Reported
1.3100
1.3100
-905.2300
48,297.7250
53,239.8960
Total Expenses
575,576.5430
575,576.5430
458,979.8090
374,044.2820
400,403.7530
Net Income from Continuing & Discontinued Operation
29,773.1540
29,773.1540
-3,067.4440
29,691.1160
31,083.8060
Normalized Income
-7,804.0615
-7,804.0615
-10,044.6744
30,059.9236
34,299.5175
Interest Expense
12,995.5630
12,995.5630
9,187.9470
10,400.8070
11,440.7590
Net Interest Income
-12,995.5630
-12,995.5630
-9,187.9470
-10,400.8070
-11,440.7590
EBIT
50,548.0580
50,548.0580
7,816.3080
47,830.8800
51,117.1890
EBITDA
97,262.5390
97,262.5390
34,712.4560
70,055.7900
73,197.2530
Reconciled Cost of Revenue
431,103.2420
431,103.2420
313,112.3260
259,254.0900
291,993.9360
Reconciled Depreciation
46,714.4810
46,714.4810
26,896.1480
22,224.9100
22,080.0640
Net Income from Continuing Operation Net Minority Interest
29,773.1540
29,773.1540
-3,067.4440
29,691.1160
31,083.8060
Total Unusual Items Excluding Goodwill
49,969.2170
49,969.2170
8,721.5380
-466.8450
-4,122.7070
Total Unusual Items
49,969.2170
49,969.2170
8,721.5380
-466.8450
-4,122.7070
Normalized EBITDA
47,293.3220
47,293.3220
25,990.9180
70,522.6350
77,319.9600
Tax Rate for Calcs
0.0002
0.0002
0.0002
0.0002
0.0002
Tax Effect of Unusual Items
12,392.0015
12,392.0015
1,744.3076
-98.0374
-906.9955
12/31/2020 - 11/2/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade